One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood-2018-99-112983
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 2 |
Affiliation: University Hospital Brno, Oncopeptides (Sweden), University of Paris-Saclay, Institut Polytechnique de Paris, Institut Gustave Roussy, Confluent Private Hospital, Claude Bernard University Lyon 1, Hôpital Lyon Sud, Hospital de Sant Pau, Hospital Universitari Germans Trias i Pujol, General University Hospital in Prague, Centre Hospitalier Régional Universitaire de Brest, The Ohio State University, University Hospital Ostrava, Clinique Victor Hugo, Centre Jean Bernard, University of Hradec Králové, Dana-Farber Cancer Institute, Harvard University, University of Florida Health, Hospital Universitario 12 De Octubre, Complejo Hospitalario de Salamanca
The OP-104 Anchor Study: A Phase 1/2 Study of Safety and Efficacy of Melflufen and Dexamethasone in Combination with Either Bortezomib or Daratumumab in Patients with Rrmm; First Report on Phase 1 Data
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
